Jolanta Airey, MD
Cynata Therapeutics Limited
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jolanta Airey, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05643638 · A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHDCynata Therapeutics Limited · terminated · Graft Versus Host Disease, Acute · study director
- Ph1NCT05165628 · Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot UlcersCynata Therapeutics Limited · completed · Diabetic Foot Ulcer, Cutaneous Ulcer · study director
- Ph1NCT04537351 · The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying CauseCynata Therapeutics Limited · completed · Covid19, Acute Respiratory Distress Syndrome · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.